- Report
- June 2023
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Book
- June 2020
- 198 Pages
- Report
- November 2021
- 527 Pages
Global
From €3641EUR$4,000USD£3,092GBP
- Report
- November 2021
- 802 Pages
Global
From €4551EUR$5,000USD£3,865GBP
- Report
- November 2021
- 233 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- November 2021
- 1165 Pages
Global
From €5461EUR$6,000USD£4,638GBP
- Report
- February 2023
- 280 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- July 2022
- 315 Pages
Global
From €2447EUR$2,688USD£2,078GBP
€3495EUR$3,840USD£2,969GBP
- Report
- May 2022
- 225 Pages
Global
From €2202EUR$2,419USD£1,870GBP
€3146EUR$3,456USD£2,672GBP
- Report
- July 2021
- 243 Pages
Global
From €2365EUR$2,598USD£2,009GBP
€3379EUR$3,712USD£2,870GBP
- Book
- February 2025
- 560 Pages
- Book
- August 2024
- 416 Pages
- Book
- December 2022
- 560 Pages
- Book
- September 2018
- 576 Pages
- Book
- May 2018
- 1064 Pages

The oligonucleotide market is a subset of the biotechnology industry that focuses on the production and sale of oligonucleotides, which are short strands of nucleic acids used in a variety of applications. Oligonucleotides are used in research, diagnostics, and therapeutics, and are essential components of many biotechnological processes. They are used in a variety of applications, including gene expression analysis, gene cloning, and gene sequencing.
The oligonucleotide market is expected to grow in the coming years due to increasing demand for biotechnological products and services. The market is driven by advances in technology, such as the development of new sequencing techniques, and the increasing use of oligonucleotides in drug discovery and development.
Some of the major companies in the oligonucleotide market include Thermo Fisher Scientific, Illumina, Agilent Technologies, Merck KGaA, and Qiagen. These companies are involved in the production and sale of oligonucleotides, as well as the development of new technologies and products. Show Less Read more